Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Journey Medical Corp (DERM)

Journey Medical Corp (DERM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 104,268
  • Shares Outstanding, K 20,013
  • Annual Sales, $ 79,180 K
  • Annual Income, $ -3,850 K
  • 60-Month Beta 0.93
  • Price/Sales 1.30
  • Price/Cash Flow 28.43
  • Price/Book 7.93
Trade DERM with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.12
  • Low Estimate -0.17
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +69.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.40 +18.34%
on 06/06/24
6.15 -15.28%
on 06/12/24
+0.76 (+17.08%)
since 06/05/24
3-Month
3.20 +62.81%
on 05/21/24
6.15 -15.28%
on 06/12/24
+1.53 (+41.58%)
since 04/05/24
52-Week
1.60 +225.63%
on 07/28/23
8.11 -35.76%
on 12/20/23
+3.16 (+154.15%)
since 07/05/23

Most Recent Stories

More News
Journey Medical Corporation Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights

Second quarter 2022 net revenue increased 20% to $18.3 million versus the same quarter of 2021 DFD-29 Phase 3 studies 45% enrolled to date; 9 additional...

DERM : 5.21 (+1.17%)
FBIO : 1.8000 (+2.27%)
Journey Medical Corporation Announces Settlement Agreements Pertaining to QBREXZA®, AMZEEQ® and ZILXI® Patent Exclusivity

SCOTTSDALE, Ariz., May 24, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical” or the “Company”), a commercial-stage...

FBIO : 1.8000 (+2.27%)
DERM : 5.21 (+1.17%)
Journey Medical Corporation to Present at the B. Riley Securities 22nd Annual Institutional Investor Conference

SCOTTSDALE, Ariz., May 23, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM), a commercial-stage pharmaceutical...

FBIO : 1.8000 (+2.27%)
DERM : 5.21 (+1.17%)
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies...

ACST : 2.89 (-0.36%)
LPTH : 1.3500 (-1.46%)
RCAT : 1.1500 (-1.71%)
IONM : 0.3107 (-0.58%)
PYR : 0.3799 (unch)
OSS : 2.23 (+1.83%)
MODD : 1.4900 (+6.43%)
STRN : 1.3400 (+0.75%)
AEYE : 19.36 (-8.94%)
SMFL : 2.57 (-5.51%)
LFMD : 6.57 (-3.52%)
SURG : 2.99 (+2.75%)
Journey Medical Corporation Reports First Quarter 2022 Financial Results and Recent Corporate Highlights

Generated record revenue of $23.3 million for the first quarter of 2022 First patient dosed in Phase 3 clinical program evaluating DFD-29 for the...

DERM : 5.21 (+1.17%)
FBIO : 1.8000 (+2.27%)
Journey Medical Corporation to Announce First Quarter 2022 Financial Results on May 10, 2022

Company to host conference call to discuss financial results and provide a corporate update on May 10, 2022 at 4:30 p.m. ET...

FBIO : 1.8000 (+2.27%)
DERM : 5.21 (+1.17%)
Journey Medical Corporation to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities

SCOTTSDALE, Ariz., April 04, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM), a commercial-stage pharmaceutical...

FBIO : 1.8000 (+2.27%)
DERM : 5.21 (+1.17%)
Journey Medical Corporation Reports Full-Year 2021 Financial Results and Recent Corporate Highlights

Generated record net product revenues of $63.1 million for the full year 2021 Completed initial public offering of common stock and raised $30.6 million...

DERM : 5.21 (+1.17%)
FBIO : 1.8000 (+2.27%)
Journey Medical Corporation to Release Year End 2021 Financial Results and Provide Corporate Update on March 23, 2022

Company to hold conference call on March 23, 2022 at 4:30 p.m. ET...

FBIO : 1.8000 (+2.27%)
DERM : 5.21 (+1.17%)
Journey Medical Corporation Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating DFD-29 (Minocycline Modified Release Capsules 40 mg) for the Treatment of Rosacea

Published Phase 2 clinical data show DFD-29 had approximately double the efficacy compared to Doxycycline capsules 40 mg on reducing total inflammatory...

FBIO : 1.8000 (+2.27%)
DERM : 5.21 (+1.17%)

Business Summary

Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.

See More

Key Turning Points

3rd Resistance Point 5.54
2nd Resistance Point 5.44
1st Resistance Point 5.32
Last Price 5.21
1st Support Level 5.10
2nd Support Level 5.00
3rd Support Level 4.88

See More

52-Week High 8.11
Fibonacci 61.8% 5.62
Last Price 5.21
Fibonacci 50% 4.86
Fibonacci 38.2% 4.09
52-Week Low 1.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar